Skip to main content
Top
Published in: Supportive Care in Cancer 9/2016

01-09-2016 | Original Article

Relationship between weight loss and parameters of skeletal muscle function in patients with advanced cancer and fatigue

Authors: P. Cresta Morgado, A. Giorlando, M. Castro, A. Navigante

Published in: Supportive Care in Cancer | Issue 9/2016

Login to get access

Abstract

Purpose

This study aims to determine the influence of significant weight loss on parameters of skeletal muscle function in a population of advanced cancer patients with fatigue.

Methods

A cross-sectional and comparative study was designed between two arms of advanced cancer patients with fatigue (fatigue numeral scale (FNS) ≥4). A arm (n = 27) with ≥5 % weight loss in the last 6 months, and B arm (n = 22) without weight loss. Muscle strength was examined by hand grip technique and measurements of body composition by bioimpedance analysis (BIA), values of hemoglobin, albumin, lactic dehydrogenase (LDH), c-reactive protein (CRP), urine creatinine, and FNS. These variables were compared between both groups and correlated within each group.

Results

here were no differences concerning parameters of muscle strength between both arms. A arm had values of CRP ≥10 ug/dl in 77 % compared with 38.5 % of B arm (p = 0.004). A arm showed a higher percentage of body cell mass (%BCM) than B arm (p = 0.005). The A arm also showed a lower percentage of fat mass (%FM) (p = 0.014) when compared to the B arm. FNS was higher in A arm (median 7 vs 5; p = 0.047). All the variables of muscle strength had a significant positive correlation. In A arm, BCM had a negative significant correlation with CRP (p = 0.021).

Conclusions

In this study, significant weight loss and high CRP did not have influence on parameters of skeletal muscular function. We consider that further studies should be necessary, preferably with longitudinal designs to evaluate these findings.
Literature
1.
go back to reference National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Cancer-related fatigue (version 2. 2015) http.//www.nccn.org/professionals physician –gls/pdf/fatigue.pdf. Accessed May 21, 2015. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Cancer-related fatigue (version 2. 2015) http.//www.​nccn.​org/​professionals physician –gls/pdf/fatigue.pdf. Accessed May 21, 2015.
2.
go back to reference Partridge A, Jacobsen P, Andersen B (2015) Challenges to standardizing the care for adult cancer survivors: highlighting ASCO’s fatigue and anxiety and depression guidelines. Am Soc Clin Oncol Educ Book: 188-194. Partridge A, Jacobsen P, Andersen B (2015) Challenges to standardizing the care for adult cancer survivors: highlighting ASCO’s fatigue and anxiety and depression guidelines. Am Soc Clin Oncol Educ Book: 188-194.
3.
go back to reference Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K, Mugnier-Konrad B, Rapiti E, Allaz AF (2011) Patients ‘views about causes and preferences for the management of cancer-related fatigue—a case for non congruence with physicians? Support Care Cancer 19:363–370CrossRefPubMed Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K, Mugnier-Konrad B, Rapiti E, Allaz AF (2011) Patients ‘views about causes and preferences for the management of cancer-related fatigue—a case for non congruence with physicians? Support Care Cancer 19:363–370CrossRefPubMed
4.
go back to reference Dy SM, Lorenz KA, Naem A, Sanati H, Walling A, Asch SM (2008) Evidence-based recommendations for cancer fatigue, anorexia, depression and dyspnea. J Clin Oncol 26:3886–3895CrossRefPubMed Dy SM, Lorenz KA, Naem A, Sanati H, Walling A, Asch SM (2008) Evidence-based recommendations for cancer fatigue, anorexia, depression and dyspnea. J Clin Oncol 26:3886–3895CrossRefPubMed
5.
go back to reference Kisiel-Sajewicz K, Mellar PD, Siemionov V, Sediyova-Khoshknabi D, Wyant A, Walsh D et al (2012) Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in cancer-related fatigue. J Pain Symptom Manag 44:351–361CrossRef Kisiel-Sajewicz K, Mellar PD, Siemionov V, Sediyova-Khoshknabi D, Wyant A, Walsh D et al (2012) Lack of muscle contractile property changes at the time of perceived physical exhaustion suggests central mechanisms contributing to early motor task failure in cancer-related fatigue. J Pain Symptom Manag 44:351–361CrossRef
6.
go back to reference Campos MP, Hassan BJ, Riechelman R, Del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22:1273–1279CrossRefPubMed Campos MP, Hassan BJ, Riechelman R, Del Giglio A (2011) Cancer-related fatigue: a practical review. Ann Oncol 22:1273–1279CrossRefPubMed
7.
go back to reference Capuano G, Pavese I, Satta F, Tosti M, Palladino A, Del Grosso A, Di Palma M (2008) Correlation between anemia, unintentional weight loss and inflammatory status on cancer-related fatigue and quality of life before chemo and radiotherapy. Eur J Clin Nutr Metab 3:147–151CrossRef Capuano G, Pavese I, Satta F, Tosti M, Palladino A, Del Grosso A, Di Palma M (2008) Correlation between anemia, unintentional weight loss and inflammatory status on cancer-related fatigue and quality of life before chemo and radiotherapy. Eur J Clin Nutr Metab 3:147–151CrossRef
8.
go back to reference Saligan LN, Olson K, Filler K, Larkin D, Cramp F et al (2015) The biology of cancer-related fatigue: a review of the literature. Support Care Cancer 23:2461–2478CrossRefPubMed Saligan LN, Olson K, Filler K, Larkin D, Cramp F et al (2015) The biology of cancer-related fatigue: a review of the literature. Support Care Cancer 23:2461–2478CrossRefPubMed
9.
go back to reference Evans WJ, Morley JE, Argilés J, Bales C, Baracos V et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799CrossRefPubMed Evans WJ, Morley JE, Argilés J, Bales C, Baracos V et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799CrossRefPubMed
10.
go back to reference Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98(9):1786–1801CrossRefPubMed Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98(9):1786–1801CrossRefPubMed
11.
go back to reference Minton O, Strasser F, Radbruch L, Stone P (2012) Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment date set. J Pain Symptom Manage 43:226–235CrossRefPubMed Minton O, Strasser F, Radbruch L, Stone P (2012) Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment date set. J Pain Symptom Manage 43:226–235CrossRefPubMed
12.
go back to reference Collado-Hidalgo A, Bower JF, Ganz PA, Cole SW, Irwin MR (2006) Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759–2766CrossRefPubMed Collado-Hidalgo A, Bower JF, Ganz PA, Cole SW, Irwin MR (2006) Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759–2766CrossRefPubMed
13.
go back to reference Berger AM, Bruera E, Cimpich B (2010) Recognition and treatment of the symptom of cancer-related fatigue. Am Soc Clin Oncol Educ Book: 350-355 Berger AM, Bruera E, Cimpich B (2010) Recognition and treatment of the symptom of cancer-related fatigue. Am Soc Clin Oncol Educ Book: 350-355
14.
go back to reference Navigante A, Cresta MP, Casbadien O, López DN, Giglio R, Perman M (2013) Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care in Cancer 21(6):1585–1590. doi:10.1007/s00520-012-1774-2 CrossRef Navigante A, Cresta MP, Casbadien O, López DN, Giglio R, Perman M (2013) Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care in Cancer 21(6):1585–1590. doi:10.​1007/​s00520-012-1774-2 CrossRef
15.
go back to reference Cerchietti L, Navigante A, Peluffo G, Diament M et al (2004) Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symptom Manage 27:85–95CrossRefPubMed Cerchietti L, Navigante A, Peluffo G, Diament M et al (2004) Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symptom Manage 27:85–95CrossRefPubMed
16.
go back to reference Fearon K, Strasser F, Anker SD, Bosaeus I et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–503CrossRefPubMed Fearon K, Strasser F, Anker SD, Bosaeus I et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–503CrossRefPubMed
17.
go back to reference Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P et al (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23:1430–1453CrossRefPubMed Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P et al (2004) Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23:1430–1453CrossRefPubMed
18.
go back to reference Beberashvili I, Azar A, Sinuani I, Kadoshi H et al (2014) Longitudinal changes in bioimpedance phase angle reflect inverse changes in serum IL-6 levels in maintenance hemodialysis patients. Nutrition 30:297–304CrossRefPubMed Beberashvili I, Azar A, Sinuani I, Kadoshi H et al (2014) Longitudinal changes in bioimpedance phase angle reflect inverse changes in serum IL-6 levels in maintenance hemodialysis patients. Nutrition 30:297–304CrossRefPubMed
19.
go back to reference Hui D, Bansal S, Morgado M, Dev R, Chisholm G, Bruera E (2014) Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer 15:2207–2214CrossRef Hui D, Bansal S, Morgado M, Dev R, Chisholm G, Bruera E (2014) Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer 15:2207–2214CrossRef
20.
go back to reference Bautmans I, Gorus E, Njemani R, Mets T (2007) Handgrip performance in relation to self perceived-fatigue, physical functioning and circulating IL-6 elderly persons without inflammation. BMC Geriatr 7(5):1–8 Bautmans I, Gorus E, Njemani R, Mets T (2007) Handgrip performance in relation to self perceived-fatigue, physical functioning and circulating IL-6 elderly persons without inflammation. BMC Geriatr 7(5):1–8
21.
go back to reference Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32CrossRef Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32CrossRef
22.
go back to reference Hauser K, Rybicki L, Walsh D (2010) What’s in a name? Word descriptors of cancer-related fatigue. Palliat Med 24(7):724–730CrossRefPubMed Hauser K, Rybicki L, Walsh D (2010) What’s in a name? Word descriptors of cancer-related fatigue. Palliat Med 24(7):724–730CrossRefPubMed
23.
go back to reference Filler K, Saligan LN (2016) Defining cancer-related fatigue for biomarker discovery. Support Care Cancer 24:5–7CrossRefPubMed Filler K, Saligan LN (2016) Defining cancer-related fatigue for biomarker discovery. Support Care Cancer 24:5–7CrossRefPubMed
25.
go back to reference Gandevia SC (2001) Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 81(4):1725–1789PubMed Gandevia SC (2001) Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 81(4):1725–1789PubMed
26.
go back to reference Davis MP, Walsh D (2010) Mechanisms of fatigue. J Supp Oncol 8(4):164–174 Davis MP, Walsh D (2010) Mechanisms of fatigue. J Supp Oncol 8(4):164–174
27.
go back to reference Jensen GL, Hsiao YP, Wheeler D (2012) Adult nutrition assessment tutorial. JPEN J Parenter Enter Nutr 36:267–274CrossRef Jensen GL, Hsiao YP, Wheeler D (2012) Adult nutrition assessment tutorial. JPEN J Parenter Enter Nutr 36:267–274CrossRef
28.
go back to reference Scialla SJ, Cole RP, Bednarz L (2006) Redefining cancer-related asthenia-fatigue syndrome. J Palliat Med 5(4):866–872CrossRef Scialla SJ, Cole RP, Bednarz L (2006) Redefining cancer-related asthenia-fatigue syndrome. J Palliat Med 5(4):866–872CrossRef
29.
go back to reference Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K (2007) Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 13(21):6379–6385CrossRefPubMed Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K (2007) Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res 13(21):6379–6385CrossRefPubMed
30.
go back to reference Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P et al (2004) Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr 23:1226–1243CrossRefPubMed Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P et al (2004) Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr 23:1226–1243CrossRefPubMed
31.
go back to reference Argilés JM, Busquets S, Stemmler B, López-Soriano FJ (2014) Cancer cachexia understanding the molecular basis. Nat Rev 14:754–762CrossRef Argilés JM, Busquets S, Stemmler B, López-Soriano FJ (2014) Cancer cachexia understanding the molecular basis. Nat Rev 14:754–762CrossRef
32.
Metadata
Title
Relationship between weight loss and parameters of skeletal muscle function in patients with advanced cancer and fatigue
Authors
P. Cresta Morgado
A. Giorlando
M. Castro
A. Navigante
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3236-9

Other articles of this Issue 9/2016

Supportive Care in Cancer 9/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine